Cardiac Safety/TQT White Papers & Case Studies

  1. Considerations When Selecting A CRO For Phase I Clinical Studies
    6/17/2013

    Phase I clinical trials are an integral step in the drug development process. Specific factors can influence the timelines and success of these studies. This white paper addresses the critical success factors for Phase I clinical studies and provides guidance on the appropriate capabilities, expertise and experience to evaluate as a sponsor selects a CRO.

  2. Phase II Primary Insomnia Program In Need Of Full-Service CRO Management
    12/6/2012

    Clinilabs, a contract research organization (CRO), was selected by an international drug discovery and development company to provide full-service CRO management of a phase II primary insomnia program.

  3. Examining Rescue Studies
    11/7/2011

    The purpose of this whitepaper is to define a Rescue Study, outline the basic assumptions, including risks, in setting up such a trial based on DATATRAK’s prior experiences, and present the actions that can help avoid or mitigate these risks during a deployment.